Sales and Marketing

Showing 15 posts of 11526 posts found.

ema_building_face_web

EU recommendation for Sanofi and Regeneron’s arthritis treatment

April 24, 2017 Sales and Marketing Kevzara, NICE, sarilumab

Sanofi and Regeneron are celebrating the news that their treatment Kevzara (sarilumab) has received a positive opinion from the EMA’s …

England “really is not a good place” to get cancer, BMS UK General Manager says

April 24, 2017 Medical Communications, Research and Development, Sales and Marketing BMS, NICE, opdivo

Bristol-Myers Squibb’s UK General Manager Ben Hickey has slammed NICE over its assessment criteria and process in recommending access to …
dna_manufacture

Applied DNA Sciences agrees deal for bulk DNA manufacturing

April 21, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Applied DNA sciences, DNA manufacture

In a deal that sounds more like something to come out of a science-fiction novel, Applied DNA Sciences has agreed …
cough_syrup

FDA restricts administration of strong pain killers to children

April 21, 2017 Medical Communications, Sales and Marketing FDA, opioid

The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week has whizzed round again as we race into Spring, and a breadth of stories have piqued the interests …
teva_canada

Teva launches competitors to GSK’s Advair inhaler

April 21, 2017 Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma

GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …
it_pic

How can big data improve humanity?

April 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data

Alexander Hitchcock and Eleonora Harwich, researchers at UK think tank Reform, discuss the increasing importance of big data in the …
alpine_immune_sciences

Alpine Immune Sciences boosts prospects with Nivalis merger

April 20, 2017 Sales and Marketing Alpine Immune Sciences, Nivalis Therapeutics, merger

Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The merger sees Alpine …

FDA warns of dangers of Hyland’s homeopathic teething tablets as recall is issued

April 18, 2017 Manufacturing and Production, Sales and Marketing FDA, Hyland, recall

After months of FDA warnings, Hyland has finally issued an official voluntary recall of its homeopathic teething tablets, with the …
12324594465_18434550d7_z

Circassia stumbles with allergy treatments at clinical trial stage, again

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …
roche__tree

Roche’s drug scores expanded FDA indication in advanced bladder cancer

April 18, 2017 Manufacturing and Production, Sales and Marketing Genentech, Roche, tecentriq

Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after …
bandage

‘Smart bandages’ could offer real-time wound feedback

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Swansea University, smart bandage

The problem with bandages is that often we do not know how well a wound has healed under them until …
fdaoutsideweb

FDA warning slams St Jude’s “inadequate response” to device failures

April 13, 2017 Medical Communications, Sales and Marketing FDA, st jude medical

St Jude Medical has been hit with a warning letter from the FDA over the medical device manufacturer’s failure to …
fdaoutsideweb

FDA approves first and only tardive dyskinesia treatment

April 12, 2017 Research and Development, Sales and Marketing FDA, Neurocrine Biosciences, tardive dyskinesia

US patients suffering with tardive dyskinesia (TD) will see access to the first approved treatment in the country with the …
The Gateway to Local Adoption Series

Latest content